BRAF and melanoma: In BRAF (V600E) mutant melanoma cells, DHODH modulates transcriptional elongation and its inhibition completely abrogated cell growth, providing the potential therapeutic strategy through combination of DHODH and BRAF (V600E) inhibitors (101).